Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2022-08-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$137.5m reported value -1.0% vs Q1 2022
64positions
73.2%in top 10
1 new 15 added 10 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRISTOL-MYERS SQUIBB CO COM BMY BMY 727,785 $56.0m40.76% 40.76% ReducedShares held: Q3 2021 796.1k, Q4 2021 766.1k, Q1 2022 754.1k, Q2 2022 727.8k -26.3k -26,321 -3.5%
2 ELUTIA INC CL A COM ELUT ELUT 1,418,123 $10.0m7.29% 7.29% AddedShares held: Q3 2021 50.0k, Q4 2021 1.4m, Q1 2022 1.4m, Q2 2022 1.4m +200 +200 0.0%
3 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 85,240 $8.3m6.04% 6.04% ReducedShares held: Q3 2021 80.2k, Q4 2021 89.2k, Q1 2022 89.2k, Q2 2022 85.2k -4.0k -4,000 -4.5%
4 QUIDEL CORP COM QDEL QDEL 61,306 $6.0m4.33% 4.33% AddedShares held: Q3 2021 59.7k, Q4 2021 59.7k, Q1 2022 59.7k, Q2 2022 61.3k +1.6k +1,622 2.7%
5 FOGHORN THERAPEUTICS INC COM FHTX FHTX 284,843 $3.9m2.82% 2.82% ReducedShares held: Q3 2021 314.1k, Q4 2021 314.1k, Q1 2022 294.1k, Q2 2022 284.8k -9.3k -9,300 -3.2%
6 OVINTIV INC COM OVV OVV 84,200 $3.7m2.71% 2.71% AddedShares held: Q3 2021 34.2k, Q4 2021 34.2k, Q1 2022 34.2k, Q2 2022 84.2k +50.0k +50,000 146.2%
7 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 15,000 $3.5m2.57% 2.57% ReducedShares held: Q3 2021 18.0k, Q4 2021 18.0k, Q1 2022 18.0k, Q2 2022 15.0k -3.0k -3,000 -16.7%
8 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 249,400 $3.5m2.56% 2.56% AddedShares held: Q3 2021 199.4k, Q4 2021 199.4k, Q1 2022 199.4k, Q2 2022 249.4k +50.0k +50,000 25.1%
9 BIODESIX INC COM COM 1,811,412 $2.9m2.13% 2.13% AddedShares held: Q3 2021 1.1m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.8m +558.7k +558,659 44.6%
10 PROTHENA CORP PLC SHS PRTA PRTA 102,548 $2.8m2.03% 2.03% AddedShares held: Q3 2021 40.2k, Q4 2021 40.2k, Q1 2022 42.0k, Q2 2022 102.5k +60.6k +60,570 144.3%
11 CONTINENTAL RES INC COM CLR CLR 38,600 $2.5m1.84% 1.84% UnchangedShares held: Q3 2021 38.6k, Q4 2021 38.6k, Q1 2022 38.6k, Q2 2022 38.6k
12 ALBIREO PHARMA INC COM BIOD BIOD 113,000 $2.2m1.63% 1.63% UnchangedShares held: Q3 2021 113.0k, Q4 2021 113.0k, Q1 2022 113.0k, Q2 2022 113.0k
13 ACCELERATE DIAGNOSTICS INC COM COM 2,252,388 $2.2m1.63% 1.63% UnchangedShares held: Q3 2021 2.3m, Q4 2021 2.3m, Q1 2022 2.3m, Q2 2022 2.3m
14 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 15,000 $2.2m1.59% 1.59% AddedShares held: Q3 2021 10.0k, Q4 2021 12.0k, Q1 2022 14.0k, Q2 2022 15.0k +1.0k +1,000 7.1%
15 PHREESIA INC COM PHR PHR 82,700 $2.1m1.50% 1.50% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 10.0k, Q2 2022 82.7k +72.7k +72,700 727.0%
16 MASIMO CORP COM MASI MASI 15,280 $2.0m1.45% 1.45% AddedShares held: Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 9.3k, Q2 2022 15.3k +6.0k +6,000 64.7%
17 ALKERMES PLC SHS ALKS ALKS 50,000 $1.5m1.08% 1.08% UnchangedShares held: Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 50.0k
18 GOSSAMER BIO INC COM GOSS GOSS 159,088 $1.3m0.97% 0.97% AddedShares held: Q3 2021 40.0k, Q4 2021 100.0k, Q1 2022 129.1k, Q2 2022 159.1k +30.0k +30,000 23.2%
19 HARROW INC COM HROW HROW 180,000 $1.3m0.95% 0.95% UnchangedShares held: Q3 2021 180.0k, Q4 2021 180.0k, Q1 2022 180.0k, Q2 2022 180.0k
20 KARYOPHARM THERAPEUTICS INC COM COM 269,332 $1.2m0.88% 0.88% UnchangedShares held: Q3 2021 246.0k, Q4 2021 246.0k, Q1 2022 269.3k, Q2 2022 269.3k
21 CORCEPT THERAPEUTICS INC COM CORT CORT 50,000 $1.2m0.86% 0.86% UnchangedShares held: Q3 2021 50.0k, Q4 2021 50.0k, Q1 2022 50.0k, Q2 2022 50.0k
22 CYTOKINETICS INC COM NEW CYTK CYTK 25,000 $982.0k0.71% 0.71% UnchangedShares held: Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 25.0k
23 AVEO PHARMACEUTICALS INC COM NEW AVEO AVEO 140,000 $918.0k0.67% 0.67% UnchangedShares held: Q3 2021 40.0k, Q4 2021 140.0k, Q1 2022 140.0k, Q2 2022 140.0k
24 PIONEER NAT RES CO COM PXD PXD 3,800 $848.0k0.62% 0.62% UnchangedShares held: Q3 2021 3.8k, Q4 2021 3.8k, Q1 2022 3.8k, Q2 2022 3.8k
25 EQUITRANS MIDSTREAM CORP COM ETRN ETRN 133,050 $846.0k0.62% 0.62% UnchangedShares held: Q3 2021 133.1k, Q4 2021 133.1k, Q1 2022 133.1k, Q2 2022 133.1k
26 INHIBRX INC COM INBX INBX 70,448 $800.0k0.58% 0.58% AddedShares held: Q3 2021 0, Q4 2021 40.0k, Q1 2022 50.4k, Q2 2022 70.4k +20.0k +20,000 39.6%
27 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 59,833 $790.0k0.57% 0.57% AddedShares held: Q3 2021 0, Q4 2021 28.0k, Q1 2022 34.3k, Q2 2022 59.8k +25.5k +25,500 74.3%
28 DOCGO INC COM DCGO DCGO 110,000 $785.0k0.57% 0.57% UnchangedShares held: Q3 2021 0, Q4 2021 10.0k, Q1 2022 110.0k, Q2 2022 110.0k
29 INARI MED INC COM NARI NARI 10,000 $680.0k0.49% 0.49% AddedShares held: Q3 2021 7.0k, Q4 2021 7.0k, Q1 2022 8.0k, Q2 2022 10.0k +2.0k +2,000 25.0%
30 SOLENO THERAPEUTICS INC COM COM 3,676,899 $680.0k0.49% 0.49% UnchangedShares held: Q3 2021 876.9k, Q4 2021 876.9k, Q1 2022 3.7m, Q2 2022 3.7m
31 IMMUNOGEN INC COM IMGN IMGN 150,000 $675.0k0.49% 0.49% ReducedShares held: Q3 2021 190.0k, Q4 2021 190.0k, Q1 2022 190.0k, Q2 2022 150.0k -40.0k -40,000 -21.1%
32 ARVINAS INC COM ARVN ARVN 15,000 $631.0k0.46% 0.46% UnchangedShares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
33 CONTRAFECT CORP COM CFRX CFRX 200,000 $614.0k0.45% 0.45% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
34 TURNING POINT THERAPEUTICS I COM COM 8,000 $602.0k0.44% 0.44% UnchangedShares held: Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k, Q2 2022 8.0k
35 CULLINAN THERAPEUTICS INC COM CGEM CGEM 45,114 $578.0k0.42% 0.42% UnchangedShares held: Q3 2021 45.1k, Q4 2021 45.1k, Q1 2022 45.1k, Q2 2022 45.1k
36 APELLIS PHARMACEUTICALS INC COM APLS APLS 12,000 $543.0k0.39% 0.39% UnchangedShares held: Q3 2021 12.0k, Q4 2021 12.0k, Q1 2022 12.0k, Q2 2022 12.0k
37 CHEMOCENTRYX INC COM CCXI CCXI 20,000 $496.0k0.36% 0.36% UnchangedShares held: Q3 2021 25.0k, Q4 2021 20.0k, Q1 2022 20.0k, Q2 2022 20.0k
38 NEKTAR THERAPEUTICS COM COM 128,000 $486.0k0.35% 0.35% UnchangedShares held: Q3 2021 72.0k, Q4 2021 100.0k, Q1 2022 128.0k, Q2 2022 128.0k
39 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 4,000 $432.0k0.31% 0.31% UnchangedShares held: Q3 2021 4.0k, Q4 2021 4.0k, Q1 2022 4.0k, Q2 2022 4.0k
40 AMICUS THERAPEUTICS INC COM FOLD FOLD 38,000 $408.0k0.30% 0.30% UnchangedShares held: Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k, Q2 2022 38.0k
41 BLUEBIRD BIO INC COM COM 98,000 $406.0k0.30% 0.30% AddedShares held: Q3 2021 84.0k, Q4 2021 84.0k, Q1 2022 84.0k, Q2 2022 98.0k +14.0k +14,000 16.7%
42 VENTYX BIOSCIENCES INC COM VTYX VTYX 33,000 $404.0k0.29% 0.29% AddedShares held: Q3 2021 0, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 33.0k +8.0k +8,000 32.0%
43 KALVISTA PHARMACEUTICALS INC COM KALV KALV 40,000 $394.0k0.29% 0.29% UnchangedShares held: Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k, Q2 2022 40.0k
44 SILK RD MED INC COM SILK SILK 10,000 $364.0k0.26% 0.26% UnchangedShares held: Q3 2021 0, Q4 2021 8.0k, Q1 2022 10.0k, Q2 2022 10.0k
45 XENCOR INC COM XNCR XNCR 12,300 $337.0k0.25% 0.25% UnchangedShares held: Q3 2021 12.3k, Q4 2021 12.3k, Q1 2022 12.3k, Q2 2022 12.3k
46 XENON PHARMACEUTICALS INC COM XENE XENE 10,000 $304.0k0.22% 0.22% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 10.0k
47 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 38,000 $301.0k0.22% 0.22% UnchangedShares held: Q3 2021 38.0k, Q4 2021 38.0k, Q1 2022 38.0k, Q2 2022 38.0k
48 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 30,000 $291.0k0.21% 0.21% UnchangedShares held: Q3 2021 30.0k, Q4 2021 30.0k, Q1 2022 30.0k, Q2 2022 30.0k
49 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 8,000 $225.0k0.16% 0.16% UnchangedShares held: Q3 2021 8.0k, Q4 2021 8.0k, Q1 2022 8.0k, Q2 2022 8.0k
50 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 20,000 $212.0k0.15% 0.15% UnchangedShares held: Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k, Q2 2022 20.0k
51 G1 THERAPEUTICS INC COM GTHX GTHX 40,000 $198.0k0.14% 0.14% UnchangedShares held: Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k, Q2 2022 40.0k
52 STOKE THERAPEUTICS INC COM STOK STOK 15,000 $198.0k0.14% 0.14% UnchangedShares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
53 IVERIC BIO INC COM OPHT OPHT 15,000 $144.0k0.10% 0.10% UnchangedShares held: Q3 2021 15.0k, Q4 2021 15.0k, Q1 2022 15.0k, Q2 2022 15.0k
54 INFLARX NV COM IFRX IFRX 70,000 $102.0k0.07% 0.07% UnchangedShares held: Q3 2021 70.0k, Q4 2021 70.0k, Q1 2022 70.0k, Q2 2022 70.0k
55 CONCERT PHARMACEUTICALS INC COM CNCE CNCE 20,000 $84.0k0.06% 0.06% UnchangedShares held: Q3 2021 20.0k, Q4 2021 20.0k, Q1 2022 20.0k, Q2 2022 20.0k
56 ANGION BIOMEDICA CORP COM COM 54,392 $62.0k0.05% 0.05% UnchangedShares held: Q3 2021 54.4k, Q4 2021 54.4k, Q1 2022 54.4k, Q2 2022 54.4k
57 LAIRD SUPERFOOD INC COM STK LSF LSF 28,000 $53.0k0.04% 0.04% UnchangedShares held: Q3 2021 14.0k, Q4 2021 18.0k, Q1 2022 28.0k, Q2 2022 28.0k
58 ASPIRA WOMENS HEALTH INC COM COM 83,104 $49.0k0.04% 0.04% ReducedShares held: Q3 2021 103.1k, Q4 2021 103.1k, Q1 2022 103.1k, Q2 2022 83.1k -20.0k -20,000 -19.4%
59 YIELD10 BIOSCIENCE INC COM COM 18,750 $42.0k0.03% 0.03% UnchangedShares held: Q3 2021 18.8k, Q4 2021 18.8k, Q1 2022 18.8k, Q2 2022 18.8k
60 SIENTRA INC COM SIEN SIEN 40,000 $34.0k0.02% 0.02% UnchangedShares held: Q3 2021 40.0k, Q4 2021 40.0k, Q1 2022 40.0k, Q2 2022 40.0k
61 AKEBIA THERAPEUTICS INC COM AKBA AKBA 0 $00.00% 0.00% ReducedShares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 20.0k, Q2 2022 0 -20.0k -20,000 -100.0%
62 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 0 $00.00% 0.00% ReducedShares held: Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k, Q2 2022 0 -300.0k -300,000 -100.0%
63 BIOGEN INC COM BIIB BIIB 0 $00.00% 0.00% ReducedShares held: Q3 2021 12.6k, Q4 2021 12.6k, Q1 2022 10.1k, Q2 2022 0 -10.1k -10,100 -100.0%
64 VANDA PHARMACEUTICALS INC COM VNDA VNDA 0 $00.00% 0.00% ReducedShares held: Q3 2021 80.0k, Q4 2021 60.0k, Q1 2022 50.0k, Q2 2022 0 -50.0k -50,000 -100.0%